![Mirko Scherer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mirko Scherer
Fondateur chez
Charly SpA
Profil
Dr. Mirko Scherer is a Chief Technology Officer at Charly SpA and a Chief Executive Officer at TVM Capital China Ltd. Dr. Scherer was previously employed as an Independent Non-Executive Director by Aptorum Group Ltd., a Non-Executive Director by Quantapore, Inc., a Co-Managing Director by KI Kapital GmbH, and a Chief Financial Officer by GPC Biotech AG.
He also served on the board at Frankfurt Stock Exchange and Stichting Preferente Aandelen Qiagen.
He received his undergraduate degree from the University of Mannheim, an MBA from Harvard Business School and a doctorate degree from EBS Universität für Wirtschaft und Recht gGmbH.
Postes actifs de Mirko Scherer
| Sociétés | Poste | Début |
|---|---|---|
Charly SpA
 Charly SpA Packaged SoftwareTechnology Services Offers automated financial advisory platform for startups | Fondateur | 01/03/2016 |
TVM Capital China Ltd. | Directeur Général | 01/03/2015 |
Anciens postes connus de Mirko Scherer
| Sociétés | Poste | Fin |
|---|---|---|
Stichting Preferente Aandelen Qiagen | Directeur/Membre du Conseil | 01/01/2019 |
Quantapore, Inc.
 Quantapore, Inc. BiotechnologyHealth Technology Develops nanopore based nucleic acid sequencing technology | Directeur/Membre du Conseil | 01/07/2018 |
KI Kapital GmbH
 KI Kapital GmbH Investment ManagersFinance KI Kapital invests in companies located in Europe. The firm focuses on companies operating across a broad range of sectors and industries. It provides financing for later stage capital requirements. | Corporate Officer/Principal | 01/02/2014 |
GPC Biotech AG
 GPC Biotech AG Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes new anticancer drugs | Fondateur | 04/12/2007 |
Börse Frankfurt
 Börse Frankfurt Investment Banks/BrokersFinance Operates as stock market | Directeur/Membre du Conseil | 01/01/2007 |
Formation de Mirko Scherer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
93
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
GPC Biotech AG
GPC Biotech AG Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes new anticancer drugs | Commercial Services |
University of Mannheim
 University of Mannheim Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EBS Universität für Wirtschaft und Recht gGmbH
 EBS Universität für Wirtschaft und Recht gGmbH Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KI Kapital GmbH
KI Kapital GmbH Investment ManagersFinance KI Kapital invests in companies located in Europe. The firm focuses on companies operating across a broad range of sectors and industries. It provides financing for later stage capital requirements. | Finance |
Börse Frankfurt
Börse Frankfurt Investment Banks/BrokersFinance Operates as stock market | Finance |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TVM Capital China Ltd. | |
Quantapore, Inc.
Quantapore, Inc. BiotechnologyHealth Technology Develops nanopore based nucleic acid sequencing technology | Health Technology |
Charly SpA
Charly SpA Packaged SoftwareTechnology Services Offers automated financial advisory platform for startups | Technology Services |
Aptorum Group Ltd.
 Aptorum Group Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutic and diagnostic products | Health Technology |
Stichting Preferente Aandelen Qiagen |
